Human Mesenchymal Stem Cells Partially Reverse Infertility in Chemotherapy-Induced Ovarian Failure
- Sara A. Mohamed,
- Shahinaz M. Shalaby,
- Mohamed Abdelaziz,
- ,
- William D Hill,
- Nahed Ismail
- Mansoura University,
- Medical College of Georgia,
- Tanta University,
- ,
- ,
- University of Pittsburgh
Open access
Sustainable Development Goals
- SDG 3 Good Health and Well
Abstract
Introduction: Chemotherapy is the most commonly used modality to treat human cancers; however, in many cases it causes irreversible ovarian failure. In this work, we plan to evaluate the restorative function of human bone marrow mesenchymal stem cells (BMSCs) in a chemotherapy-induced ovarian failure mouse model. Methods: Acclimatized 4 to 6 week-old female mice (C57BL/6) were assigned randomly to a vehicle-treated control group (group 1), chemotherapy-treated group followed by vehicle alone (group 2), or chemotherapy-treated group followed by stem cell intraovarian injection (group 3). Outcomes were evaluated using immunohistochemistry (IHC), serum hormonal assays, and estrous cycle monitoring and breeding potential. Results: Post BMSCs administration, group 3 promptly showed detectable vaginal smears with estrogenic changes. Increase in total body weight, ovarian weight, and weight of estrogen-responsive organs (uterus and liver) was observed at 2 weeks and continued to end of the experiment. Hematoxylin and Eosin histological evaluation of the ovaries demonstrated a higher mean follicle count in group 3 than in group 2. Group 3 had lower follicle-stimulating hormone (FSH) levels (P =.03) and higher anti-Müllerian hormone serum (AMH) levels (P =.0005) than group 2. The IHC analysis demonstrated higher expression of AMH, FSH receptor, inhibin A, and inhibin B in growing follicles of group 3 versus group 2. Tracking studies demonstrated that human BMSCs evenly repopulated the growing follicles in treated ovaries. Importantly, breeding data showed significant increases in the pregnancies numbers, 2 pregnancies in group 1 and 12 in group 3 (P =.02). Conclusions: Intraovarian administered BMSCs are able to restore ovarian hormone production and reactivate folliculogenesis in chemotherapy-induced ovarian failure mouse model.
Publication Information
Output type
Original language
English (US)Pages from-to (Number of pages)
Pages 51-63 (13 pages)Journal (Volume, Issue Number)
Reproductive Sciences (Volume 25, Issue 1)Publication milestones
- Published - 01/01/2018
Publication status
ISSN
1933-7191Publication IDs
- Scopus: 85037972146
- PubMed: 28460567
